TMC Life Sciences Berhad (KLSE:TMCLIFE)
Malaysia · Delayed Price · Currency is MYR 0.4450
+0.0050 (1.14%)
At close: Aug 28, 2026
TMC Life Sciences Berhad Income Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 393.03 | 345.54 | 346.42 | 311.44 | 243.77 |
Other Revenue | - | 0.1 | - | 0.11 | - |
| 393.03 | 345.63 | 346.42 | 311.56 | 243.77 | |
Revenue Growth | 13.71% | -0.23% | 11.19% | 27.81% | 21.27% |
Cost of Revenue | 257.6 | 235.97 | 208.4 | 185.5 | 155.89 |
Gross Profit | 135.42 | 109.67 | 138.02 | 126.06 | 87.88 |
Other Operating Expenses | 67.74 | 63.36 | 52.75 | 53 | 39.94 |
Operating Expenses | 105.07 | 97.46 | 80.66 | 79.01 | 55.79 |
Operating Income | 30.36 | 12.21 | 57.36 | 47.05 | 32.09 |
Interest Expense | -7.49 | -9.32 | -10.25 | -9.4 | -2.09 |
Interest & Investment Income | 2.86 | 4.17 | 5.47 | 3.25 | 2 |
EBT Excluding Unusual Items | 25.73 | 7.06 | 52.58 | 40.89 | 32 |
Gain (Loss) on Sale of Assets | 0 | 0.01 | - | - | - |
Other Unusual Items | 0.01 | 0 | 0.04 | - | 0.18 |
Pretax Income | 25.74 | 7.07 | 52.62 | 40.89 | 32.18 |
Income Tax Expense | 8.36 | 3.47 | 11.97 | 1.63 | -9.21 |
Net Income | 17.38 | 3.61 | 40.65 | 39.26 | 41.39 |
Net Income to Common | 17.38 | 3.61 | 40.65 | 39.26 | 41.39 |
Net Income Growth | 381.97% | -91.13% | 3.54% | -5.15% | 104.35% |
Shares Outstanding (Basic) | 1,742 | 1,742 | 1,742 | 1,742 | 1,742 |
Shares Outstanding (Diluted) | 1,742 | 1,742 | 1,742 | 1,742 | 1,742 |
Shares Change | - | - | - | - | - |
EPS (Basic) | 0.01 | 0.00 | 0.02 | 0.02 | 0.02 |
EPS (Diluted) | 0.01 | 0.00 | 0.02 | 0.02 | 0.02 |
EPS Growth | 381.98% | -91.13% | 3.71% | -5.31% | 104.85% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 43.96 | -18.2 | 49.41 | 22.61 | -32.04 |
Free Cash Flow Per Share | 0.03 | -0.01 | 0.03 | 0.01 | -0.02 |
Dividend Per Share | 0.006 | 0.002 | 0.005 | 0.004 | 0.003 |
Dividend Growth | 209.34% | -61.96% | 16.65% | 51.97% | 24.74% |
Gross Margin | 34.46% | 31.73% | 39.84% | 40.46% | 36.05% |
Operating Margin | 7.72% | 3.53% | 16.56% | 15.10% | 13.16% |
Profit Margin | 4.42% | 1.04% | 11.73% | 12.60% | 16.98% |
Free Cash Flow Margin | 11.19% | -5.27% | 14.26% | 7.26% | -13.15% |
EBITDA | 58.47 | 37.81 | 80.28 | 68.43 | 44.62 |
EBITDA Margin | 14.88% | 10.94% | 23.17% | 21.96% | 18.30% |
D&A For EBITDA | 28.11 | 25.6 | 22.92 | 21.38 | 12.54 |
EBIT | 30.36 | 12.21 | 57.36 | 47.05 | 32.09 |
EBIT Margin | 7.72% | 3.53% | 16.56% | 15.10% | 13.16% |
Effective Tax Rate | 32.46% | 49.01% | 22.75% | 3.99% | - |